ND

Nikhil Dnyandev Satpute

Active Director Director DIN 11132878
DIN 11132878 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nikhil Dnyandev Satpute

Data last updated:

Nikhil Dnyandev Satpute is a Director at Arogyasadan Medical Private Limited (since 2025).

DIN 11132878
Primary Designation Director
First Appointment 30 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arogyasadan Medical Private Limited U86201PN2025PTC242560
Director30 May 20252025Active

Directorship timeline

Open interactive timeline →
Arogyasadan Medical Private Limited
Premium access

Shareholding and investment profile for Nikhil Dnyandev Satpute

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikhil Dnyandev Satpute

Nikhil Dnyandev Satpute currently holds 1 directorship: Arogyasadan Medical Private Limited (Director, since 30 May 2025).

Nikhil Dnyandev Satpute was first appointed on 30 May 2025 as Director at Arogyasadan Medical Private Limited.

The current boards of Nikhil Dnyandev Satpute's companies include Aarti Dhananjay Ware (Arogyasadan Medical Private Limited), Ashwini Namdeo Satpute (Arogyasadan Medical Private Limited), Gayatri Manohar Badarkhe (Arogyasadan Medical Private Limited), Minal Thukaram Korade (Arogyasadan Medical Private Limited), Sneha Ramesh Bharad (Arogyasadan Medical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available